AEGIS CAPITAL CORP.
810 Seventh Avenue
18thFloor
New York, NY 10019
May 1, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | BiondVax Pharmaceuticals Ltd. |
Registration Statement on Form F-1
Filed April 30, 2015
File No. 333-201283
Ladies and Gentlemen:
The undersigned, as the representative of the underwriters, hereby joins in the request of BiondVax Pharmaceuticals Ltd. to cancel the representative’s acceleration request submitted to the Securities and Exchange Commission on April 28, 2015.
Very truly yours, | ||
AEGIS CAPITAL CORP. | ||
By: AEGIS CAPITAL CORP. | ||
By: | /s/ Anthony Monaco | |
Name: Anthony M. Monaco | ||
Title: Chief Compliance Officer |